
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Ventricular tachycardia cost effectiveness of therapy
Introduction
Overview
Overview
Based on a randomized clinical trial evidence, Catheter ablation of VT is unlikely to be cost-effective compared with antiarrhythmic drug (AAD) therapy. However, more detailed and better designed studies are needed to provide more informed cost-effectiveness analyses.
Cost effectiveness of therapy
Cost effectiveness of therapy
Evidence from a randomized clinical trial has shown that Catheter ablation of VT is unlikely to be cost-effective compared with antiarrhythmic drug (AAD) therapy. However, better designed studies with more details and more frequent quality of life assessments are required to provide more informed cost-effectiveness analyses[1]
References
References
- ↑ Chen Y, Gomes M, Garcia JV, Hunter RJ, Chow AW, Dhinoja M; et al. (2020). “Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base”. Open Heart. 7 (1): e001155. doi:10.1136/openhrt-2019-001155. PMC 6999675 Check
|pmc=value (help). PMIDÂ 32076562 Check|pmid=value (help).
